1. Home
  2. TRVI vs GETY Comparison

TRVI vs GETY Comparison

Compare TRVI & GETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • GETY
  • Stock Information
  • Founded
  • TRVI 2011
  • GETY 1995
  • Country
  • TRVI United States
  • GETY United States
  • Employees
  • TRVI N/A
  • GETY N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • GETY Industrial Machinery/Components
  • Sector
  • TRVI Health Care
  • GETY Industrials
  • Exchange
  • TRVI Nasdaq
  • GETY Nasdaq
  • Market Cap
  • TRVI 725.7M
  • GETY 701.0M
  • IPO Year
  • TRVI 2019
  • GETY N/A
  • Fundamental
  • Price
  • TRVI $7.01
  • GETY $1.87
  • Analyst Decision
  • TRVI Strong Buy
  • GETY Hold
  • Analyst Count
  • TRVI 10
  • GETY 6
  • Target Price
  • TRVI $19.35
  • GETY $4.76
  • AVG Volume (30 Days)
  • TRVI 2.0M
  • GETY 612.3K
  • Earning Date
  • TRVI 11-05-2025
  • GETY 11-06-2025
  • Dividend Yield
  • TRVI N/A
  • GETY N/A
  • EPS Growth
  • TRVI N/A
  • GETY N/A
  • EPS
  • TRVI N/A
  • GETY N/A
  • Revenue
  • TRVI N/A
  • GETY $946,828,000.00
  • Revenue This Year
  • TRVI N/A
  • GETY $2.35
  • Revenue Next Year
  • TRVI N/A
  • GETY $3.07
  • P/E Ratio
  • TRVI N/A
  • GETY N/A
  • Revenue Growth
  • TRVI N/A
  • GETY 4.43
  • 52 Week Low
  • TRVI $2.36
  • GETY $1.25
  • 52 Week High
  • TRVI $8.78
  • GETY $4.49
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 44.05
  • GETY 53.36
  • Support Level
  • TRVI $7.09
  • GETY $1.72
  • Resistance Level
  • TRVI $8.78
  • GETY $1.88
  • Average True Range (ATR)
  • TRVI 0.43
  • GETY 0.09
  • MACD
  • TRVI -0.07
  • GETY -0.01
  • Stochastic Oscillator
  • TRVI 4.32
  • GETY 51.72

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About GETY Getty Images Holdings Inc.

Getty Images Holdings Inc. is a visual content creator and marketplace that offers a full range of content solutions. Through its Getty Images, Stock, and Unsplash brands, websites, and APIs, it serves customers around the world by allowing them to discover, purchase, and share visual content from photographers, illustrators, image partners, and videographers. The company generates a majority of its revenue through subscriptions, offering various subscription products on the Getty Images, iStock, and Unsplash websites. It operates and manages one operating segment, which is the business of developing and commercializing visual content. Geographically, the company generates maximum revenue from the Americas, followed by Europe, the Middle East and Africa, and the Asia-Pacific region.

Share on Social Networks: